Professional Documents
Culture Documents
1-Decreased
circulatory volume 2-Decreased local 3- Diminished
blood flow to cardiac output
kidney A- (CHF)
A-Hypovolemia A- Renal artery B- Arrhythmias,
stenosis tamponade,
B- Loss of fluids B- Drug etc.
C- Hepatorenal C-
syndrome Cardiovascular
surgery
2-Postrenal Failure
Kidney stone (usually UVJ)
Ureteropelvic junction (UPJ) or UVJ obstruction
Bladder: as neurogenic bladder or fungus ball
Urethra: posterior urethral valve; foreign body
Iatrogenic: obstructed Foley; narcotics
3- Intrinsic Acute Renal Failure
Acute tubular necrosis (ATN)
Prolonged Prerenal azotemia of any cause
Nephrotoxin-induced drugs
(aminoglycosides; amphotericin)
Primary Glomerular diseases
Hemolytic uremic syndrome
All other forms of glomerulonephritis
Intra-renal obstruction: tumor lysis
syndrome
Acute Renal Failure
Pathophysiology:
Acute renal failure (ARF) is a sudden and almost complete loss of kidney
function over a period of hours to days. ARF manifests with oliguria (less
than 400 mL/day of urine), anuria (less than 50 mL/day of urine), or
normal urine volume. The patient has high serum creatinine and BUN
levels (azotemia) and retention of other metabolic waste products
normally excreted by the kidneys.
14
Clinical course of Acute Tubular Necrosis
(ATN)
I- Onset phase: (initiating) begins with an initial
insult and lasts until cell injury occurs. It lasts from
hours to days, the clinical manifestations in this
phase include
1-decreased urine output
2-increased serum Creatinine.
The major goal during this phase is to determine the
cause
Clinical course of tubular Necrosis (ATN) cont
II- Oliguric phase or non oliguric phase (anuria)
*Oliguria = <400ml/24 hrs or <20ml/hr
*Anuria = <50ml/24 hrs
III- Diuretic phase: lasts 1-2 weeks. There is
gradual increase in urine output and may lead to
volume deficits and electrolytes imbalance.
IV- Recovery phase: lasts from months to years.
Renal function return to its normality.
Diagnosis and Assessment of ARF
In history, seek clues regarding secondary
causes - symptoms of CHF, liver disease, sepsis,
systemic vacuitis, prodromal bloody diarrhea;
birth asphyxia
Check for symptoms of primary renal disease
- UTI, gross hematuria, flank pain, Hx of strept
infection, drug exposure ( aminoglycosides or
narcotics) for bladder dysfunction
Assessment of ARF (Physical exam.) cont.
Subjective: Dysuria, nausea, weakness, and fatigue
Tachycardia and/or a drop in HR >15 b pm or drop in SBP
>15mmHg with orthostatics indicate = dehydration
Decreased mental status =decreased perfusion
Rales =fluid overload, CHF
Abdominal pain and distension = obstruction, UTI
Itching = azotemia
Assessment of ARF cont.
During physical exam, look for secondary causes
Causes of decreased effective circulatory volume -
CHF, ascites, edema, sepsis
Signs of systemic illness - (vasculitis, SLE): rash,
arthritis, purpura
Signs of obstructive uropathy: enlarged kidneys or
bladder - CHECK FOLEY.
Assessment of ARF, Labs cont.
UA:
High specific gravity = dehydration
RBCs = UTI, urolithiasis
WBCs, bacteria = UTI
Casts: RBC (glomerulonephritis), WBC
(pyelonephritis), and epithelial cells and granular casts
(ischemic damage)
Electrolytes to assess for metabolic d/o
Urine Na, Creatinine
ECG to look for peaked T waves, indicates Hyperkalemia
Assessment for ARF cont.
BUN, Cr; CBC with platelets.
Urine Analysis: hematuria, myoglobinuria,
proteinuria, RBC casts, eosinophils
Urine indices (U-osm, U-CR, U-Na )
Renal Ultra Sound (with Doppler flow to rule
out renal vein thrombosis)
Renal biopsy
Nursing diagnosis for client having ARF
Fluid volume excess related to decreased
function
Alteration in cardiac output: decreased related
to fluid volume excess.
Altered nutrition: less than body requirements
related to anorexia, nausea and vomiting.
Impairment of skin integrity related to poor
nutritional status, immobility and edema
Nursing diagnosis for client having ARF cont
Anxiety related to unexpressed serious illness
and current symptoms.
Activity intolerance related to fatigue,
anemia, retention of waste products and
dialysis procedure.
Sleep pattern disturbance related to decreased
functioning of immune system.
Knowledge deficit, disease and it
management
Anticipated problems
worsening the ARF
Adjust medicines for renal
insufficiency
Avoid Nephrotoxins if possible
Avoid intravascular volume
depletion (especially in third-
spacing or edematous patients)
Management of ARF
Ventilation and oxygenation
Circulation / perfusion
Fluids /electrolytes
Mobility
Protection/safety
Skin integrity
Nutrition
Comfort/ pain control
Psychological support
teaching
NB: Management of (ARF )
To maintain Water balance
1- Assess the Volume status
"Maintenance" is IRRELEVANT in ARF!!!
If euvolemic, give insensible + losses + UOP
If volume overloaded,
*concentrate all meds; limit oral intake
*Need frequent check on weights and BP as well as
accurate I/O
*give insensible = 30 cc/100 kcal or 400cc/M2/day
*If has any UOP, Lasix + ordered drugs may be effective
Once ARF stabilizes, fluid
replacement should be equal to
insensible losses (400) mL /day)
plus urinary or other drainage
losses to avoid hypervolemia
Management of ARF: General cont.
Discontinue/re-dose nephrotoxic drugs
38
Nursing Management of ARF (Continued)
Reducing metabolic rate. The nurse:
should reduce the patients metabolic rate to reduce catabolism and the
subsequent release of potassium and accumulation of waste products (urea
and creatinine).
may keep the patient on bed rest to reduce exertion and the metabolic rate
during the most acute stage of ARF.
should prevent or promptly treat fever and infection to decrease the
metabolic rate and catabolism.
39
Nursing Management of ARF (Continued)
Promoting pulmonary function. The nurse:
assist the patient to turn, cough, and take deep breaths frequently to
prevent atelectasis and respiratory tract infection.
Preventing infection. The nurse:
strictly observes aseptic technique when caring for the patient to minimise
the risk of infection and increased metabolism.
avoids, when possible, inserting an indwelling urinary catheter as it is a
high risk for urinary tract infection (UTI).
40